These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24566057)

  • 1. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.
    Efird JT; Choi YM; Davies SW; Mehra S; Anderson EJ; Katunga LA
    Int J Environ Res Public Health; 2014 Feb; 11(2):2328-45. PubMed ID: 24566057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
    Peter EL; Deyno S; Mtewa A; Kasali FM; Nagendrappa PB; Sesaazi D; Tolo CU; Ogwang PE
    Syst Rev; 2018 Nov; 7(1):192. PubMed ID: 30442186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
    Peter EL; Kasali FM; Deyno S; Mtewa A; Nagendrappa PB; Tolo CU; Ogwang PE; Sesaazi D
    J Ethnopharmacol; 2019 Mar; 231():311-324. PubMed ID: 30385422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
    Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
    Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007845. PubMed ID: 20166099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
    Uebanso T; Arai H; Taketani Y; Fukaya M; Yamamoto H; Mizuno A; Uryu K; Hada T; Takeda E
    J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):482-8. PubMed ID: 18202535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
    Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
    Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bitter melon to control high blood sugar].
    Praxis (Bern 1994); 2004 Dec; 93(50):2118. PubMed ID: 15646680
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
    Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
    J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania.
    Krawinkel MB; Ludwig C; Swai ME; Yang RY; Chun KP; Habicht SD
    J Ethnopharmacol; 2018 Apr; 216():1-7. PubMed ID: 29339109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the hypoglycemic effects of five commonly used herbal food supplements.
    Deng R
    Recent Pat Food Nutr Agric; 2012 Apr; 4(1):50-60. PubMed ID: 22329631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
    Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
    Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
    Krawinkel MB; Keding GB
    Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
    Miura T; Itoh Y; Iwamoto N; Kato M; Ishida T
    Biol Pharm Bull; 2004 Feb; 27(2):248-50. PubMed ID: 14758046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus.
    Peter EL; Mtewa AG; Nagendrappa PB; Kaligirwa A; Sesaazi CD
    Syst Rev; 2020 Jan; 9(1):7. PubMed ID: 31915054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
    Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
    J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.